High-grade undifferentiated sarcomas of the uterus: diagnosis, outcomes, and new treatment approaches (Q38239833)

31 August 2017

title

High-grade undifferentiated sarcomas of the uterus: diagnosis, outcomes, and new treatment approaches (English)

1 reference

31 August 2017

Patricia Pautier

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123078%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Florence Duffaud

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123078%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

publication date

1 October 2014

1 reference

31 August 2017

published in

Current Oncology Reports

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123078%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123078%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123078%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

405

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123078%20AND%20SRC:MED&resulttype=core&format=json

Treatment of uterine sarcomas.

3 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

The prognostic significance of surgery, tumor size, malignancy grade, menopausal status, and DNA ploidy in endometrial stromal sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

Endometrial stromal sarcomas and related high-grade sarcomas: immunohistochemical and molecular genetic study of 31 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

Coincident expression of beta-catenin and cyclin D1 in endometrial stromal tumors and related high-grade sarcomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

ERBB-2 gene overexpression and amplification in uterine sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

Endometrial stromal sarcoma of the uterus. A clinical and histopathological study. The Radiumhemmet series 1936-1981.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

Prognostic factors and outcome of undifferentiated endometrial sarcoma treated by multimodal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

A multi-institutional review of outcomes of endometrial stromal sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

Uterine sarcoma associated with tamoxifen use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

Diagnosis and treatment of sarcoma of the uterus. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

High grade undifferentiated uterine sarcoma: surgery, treatment, and survival outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

Predictive value of FIGO and AJCC staging systems in patients with uterine leiomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

Low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma: a comparative analysis emphasizing the importance of distinguishing between these two groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

Endometrial stromal sarcoma: a population-based analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

Endometrial stromal sarcoma metastatic to the lung: a detailed analysis of 16 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

Radiation therapy in the treatment of endometrial stromal sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

The treatment of uterine sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

Phase II trial of ifosfamide and mesna in leiomyosarcoma of the uterus: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

KIT-negative undifferentiated endometrial sarcoma with the amplified epidermal growth factor receptor gene showing a temporary response to imatinib mesylate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

Angiogenesis and antiangiogenic approaches to sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

Circulating angiogenic factor levels correlate with extent of disease and risk of recurrence in patients with soft tissue sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0405-1

Preoperative ultrasound-guided needle biopsy of 63 uterine tumors having high signal intensity upon T2-weighted magnetic resonance imaging

21 January 2018

1 reference

12 December 2020

High-grade endometrial stromal sarcomas: a clinicopathologic study of a group of tumors with heterogenous morphologic and genetic features

1 reference

12 December 2020

The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor

1 reference

12 December 2020

Impact of adjuvant treatment modalities on the management of patients with stages I-II endometrial stromal sarcoma

1 reference

12 December 2020

Feasibility study of gemcitabine plus docetaxel in advanced or recurrent uterine leiomyosarcoma and undifferentiated endometrial sarcoma in Japan.

1 reference

12 December 2020

Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases

1 reference

12 December 2020

Retrospective analysis of 318 cases of uterine sarcoma

1 reference

12 December 2020

h-Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors

1 reference

12 December 2020

Frequency of known gene rearrangements in endometrial stromal tumors

1 reference

12 December 2020

Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma

1 reference

12 December 2020

Surgical management of localized soft tissue tumors.

1 reference

12 December 2020

Heterogeneous oestrogen- and progesterone-receptor expression in low-grade endometrial stromal sarcomas-implications for therapy

1 reference

12 December 2020

Stage IA vs. IB endometrial stromal sarcoma: does the new staging system predict survival?

1 reference

12 December 2020

Resection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival

1 reference

12 December 2020

Treatment of endometrial stromal tumors

1 reference

12 December 2020

Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases.

1 reference

12 December 2020

Soft tissue sarcomas: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

1 reference

12 December 2020

An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies

1 reference

12 December 2020

Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

12 December 2020

Endometrial Stromal Sarcoma: Analysis of Treatment Failures and Survival

1 reference

12 December 2020

Treatment of recurrent or advanced uterine sarcoma. A randomized trial of doxorubicin versus doxorubicin and cyclophosphamide (a phase III trial of the Gynecologic Oncology Group)

1 reference

12 December 2020